Literature DB >> 31544349

Scaling up effective treatment of hypertension-A pathfinder for universal health coverage.

Thomas R Frieden1, Cherian V Varghese2, Sandeep P Kishore3,4, Norman R C Campbell5, Andrew E Moran1,6, Raj Padwal7, Marc G Jaffe1.   

Abstract

High blood pressure is the world's leading cause of death, but despite treatment for hypertension being safe, effective, and low cost, most people with hypertension worldwide do not have it controlled. This article summarizes lessons learned in the first 2 years of the Resolve to Save Lives (RTSL) hypertension management program, operated in coordination with the World Health Organization (WHO) and other partners. Better diagnosis, treatment, and continuity of care are all needed to improve control rates, and five necessary components have been recommended by RTSL, WHO and other partners as being essential for a successful hypertension control program. Several hurdles to hypertension control have been identified, with most related to limitations in the health care system rather than to patient behavior. Treatment according to standardized protocols should be started as soon as hypertension is diagnosed, and medical practices and health systems must closely monitor patient progress and system performance. Improvement in hypertension management and control, along with elimination of artificial trans fat and reduction of dietary sodium consumption, will improve many aspects of primary care, contribute to goals for universal health coverage, and could save 100 million lives worldwide over the next 30 years. ©2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  clinical management of high blood pressure (HBP); combination therapy; general; hypertension; pharmacologic (drug) therapy; primary care issues

Mesh:

Substances:

Year:  2019        PMID: 31544349      PMCID: PMC8030517          DOI: 10.1111/jch.13655

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  36 in total

1.  Fixed-dose combinations for hypertension.

Authors:  Sandeep P Kishore; Abdul Salam; Anthony Rodgers; Marc G Jaffe; Tom Frieden
Journal:  Lancet       Date:  2018-09-08       Impact factor: 79.321

2.  Saving an additional 100 million lives.

Authors:  Thomas R Frieden; Michael R Bloomberg
Journal:  Lancet       Date:  2017-09-12       Impact factor: 79.321

Review 3.  Cardiovascular risk reduction in hypertension: angiotensin-converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to?

Authors:  A Sindone; J Erlich; C Lee; H Newman; M Suranyi; S D Roger
Journal:  Intern Med J       Date:  2016-03       Impact factor: 2.048

4.  Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis.

Authors:  Michael P Dorsch; Brenda W Gillespie; Steven R Erickson; Barry E Bleske; Alan B Weder
Journal:  Hypertension       Date:  2011-03-07       Impact factor: 10.190

5.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

Review 6.  A systematic review of the literature comparing the practices of dispensing and non-dispensing doctors.

Authors:  David Lim; Jon Emery; Janice Lewis; V Bruce Sunderland
Journal:  Health Policy       Date:  2009-03-09       Impact factor: 2.980

Review 7.  Is chlorthalidone better than hydrochlorothiazide in reducing cardiovascular events in hypertensives?

Authors:  George C Roush; Venkata Buddharaju; Michael E Ernst
Journal:  Curr Opin Cardiol       Date:  2013-07       Impact factor: 2.161

8.  Recommended treatment protocols to improve management of hypertension globally: A statement by Resolve to Save Lives and the World Hypertension League (WHL).

Authors:  Marc G Jaffe; Thomas R Frieden; Norman R C Campbell; Kunihiro Matsushita; Lawrence J Appel; Daniel T Lackland; Xin Hua Zhang; Arumugam Muruganathan; Paul K Whelton
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-04-27       Impact factor: 3.738

9.  Full coverage for hypertension drugs in rural communities in China.

Authors:  Baorong Yu; Xiaojuan Zhang; Guijing Wang
Journal:  Am J Manag Care       Date:  2013-01-01       Impact factor: 2.229

Review 10.  The Different Therapeutic Choices with ARBs. Which One to Give? When? Why?

Authors:  Csaba András Dézsi
Journal:  Am J Cardiovasc Drugs       Date:  2016-08       Impact factor: 3.571

View more
  15 in total

1.  Take urgent action diagnosing, treating, and controlling hypertension in older women.

Authors:  Mark Gelfer; Alan Bell; Robert Petrella; Norm R C Campbell; Lyne Cloutier; Patrice Lindsay; Alexander A Leung; Dorothy Morris; Donna McLean; Ross T Tsuyuki; Shelita Dattani; Janusz Kaczorowski
Journal:  Can Fam Physician       Date:  2020-10       Impact factor: 3.275

2.  May Measurement Month 2019: results of blood pressure screening from 47 countries.

Authors:  Neil R Poulter; Claudio Borghi; Albertino Damasceno; Tazeen H Jafar; Nadia Khan; Yoshihiro Kokubo; Peter M Nilsson; Dorairaj Prabhakaran; Markus P Schlaich; Aletta E Schutte; George S Stergiou; Thomas Unger; Thomas Beaney
Journal:  Eur Heart J Suppl       Date:  2021-05-20       Impact factor: 1.803

3.  The Hypertension Canada blood pressure device recommendation listing: Empowering use of clinically validated devices in Canada.

Authors:  Raj Padwal; Angelique Berg; Mark Gelfer; Karen Tran; Jennifer Ringrose; Marcel Ruzicka; Swapnil Hiremath
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-04-27       Impact factor: 3.738

4.  Factors affecting self-management of hypertensive patients attending family medicine clinics in Riyadh, Saudi Arabia.

Authors:  Razan K AlHadlaq; Mazin M Swarelzahab; Samaher Z AlSaad; Abdulrahman K AlHadlaq; Saad M Almasari; Saleh S Alsuwayt; Naif A Alomari
Journal:  J Family Med Prim Care       Date:  2019-12-10

5.  Effect of leisure-time physical activity in controlling hypertension: a systematic review and meta-analysis protocol.

Authors:  Md Shariful Islam; Md Golam Rabbani; Ammatul Fardousi; Monaemul Islam Sizear; K M Saif-Ur-Rahman
Journal:  BMJ Open       Date:  2021-12-22       Impact factor: 2.692

6.  Global cardiovascular disease prevention and management: A collaboration of key organizations, groups, and investigators in low- and middle-income countries.

Authors:  Michael H Olsen; Dinesh Neupane; Laura K Cobb; Thomas R Frieden; Bethany Hall; Daniel T Lackland; Andrew E Moran; Qaiser Mukhtar; Michael Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-14       Impact factor: 3.738

Review 7.  Hypertension in Low- and Middle-Income Countries.

Authors:  Aletta E Schutte; Nikhil Srinivasapura Venkateshmurthy; Sailesh Mohan; Dorairaj Prabhakaran
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

Review 8.  Reducing Premature Mortality from Cardiovascular and Other Non-Communicable Diseases by One Third: Achieving Sustainable Development Goal Indicator 3.4.1.

Authors:  Thomas R Frieden; Laura K Cobb; Robynn C Leidig; Sumi Mehta; Daniel Kass
Journal:  Glob Heart       Date:  2020-07-30

9.  Cost-Effectiveness of Improved Hypertension Management in India through Increased Treatment Coverage and Adherence: A Mathematical Modeling Study.

Authors:  Hemanshu Das; Andrew E Moran; Anupam K Pathni; Bhawna Sharma; Abhishek Kunwar; Sarang Deo
Journal:  Glob Heart       Date:  2021-05-10

10.  Scaling up effective treatment of hypertension-A pathfinder for universal health coverage.

Authors:  Thomas R Frieden; Cherian V Varghese; Sandeep P Kishore; Norman R C Campbell; Andrew E Moran; Raj Padwal; Marc G Jaffe
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-23       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.